209 ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC: TOURIST

Palliative radiotherapy is widely used in stage IV non-small cell lung cancer (NSCLC). Radiotherapy dose fractionation studies have shown its utility in symptom control with improved survival at higher doses. Recent advances in radiotherapy planning and delivery offer dose escalation while reducing toxicity. However, there are no studies testing palliative radiotherapy in combination with modern systemic therapies and trials are needed to test timing, dose and fractionation in that context.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: David Woolf, Nichola Downs, Chris Sutton, Andrea Corkhill, Izabella Eberhart, Siva Saranya, Kayleigh Hill, Sean Ewings, Gabriel Rogers, Lynn Calman, Amy Hancock, Merina Ahmed, Janette Rawlinson, Jacqui Gath, Caroline Lee, Crispin Hiley, Gareth Griffiths, Tags: Trials in progress Source Type: research